Non-exudative age-related macular degeneration

Abstract

Age-related macular degeneration (AMD), also known as age-related maculopathy (ARM), is the leading cause of blindness in the Western world (1). It is also the leading cause of irreversible central vision loss in whites over 50 years of age in the United States (2). The disease affects approximately eight million people in the United States (3); its advanced form affects more than 1.75 million people (4).